Rethinking Alkylating(-Like) Agents for Solid Tumor Management

Abstract : Although old molecules, alkylating agents and platinum derivatives are still widely used in the treatment of various solid tumors. However, systemic toxicity and cellular resistance mechanisms impede their efficacy. Innovative strategies, including local administration, optimization of treatment schedule/dosage, synergistic combinations, and the encapsulation of bioactive molecules in smart, multifunctional drug delivery systems, have shown promising results in potentiating anticancer activity while circumventing such hurdles. Furthermore, questioning of the old paradigm according to which nuclear DNA is the critical target of their anticancer activity has shed light on subcellular alternative and neglected targets that obviously participate in the mediation of cytotoxicity or resistance. Thus, rethinking of the use of these pivotal antineoplastic agents appears critical to improve clinical outcomes in the management of solid tumors.
Document type :
Journal articles
Complete list of metadatas

Cited literature [31 references]  Display  Hide  Download
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, July 16, 2019 - 4:33:07 PM
Last modification on : Wednesday, July 17, 2019 - 2:13:58 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2019-10-09

Please log in to resquest access to the document



Hélène Lajous, Bénédicte Lelièvre, Elodie Vauleon, Philippe Lecomte, Emmanuel Garcion. Rethinking Alkylating(-Like) Agents for Solid Tumor Management. Trends in Pharmacological Sciences, Elsevier, 2019, 40 (5), pp.342-357. ⟨10.1016/⟩. ⟨hal-02121104⟩



Record views